Delivering support through every stage of the pharmaceutical lifecycle

As leaders in API development and manufacturing, we support our customers’ projects from discovery to full commercial manufacture, while providing them access to emerging technologies, new efficiencies, and complete continuity along the way. Our customers include global pharmaceutical corporations and innovative biotechs, both of which have unique challenges and priorities at each stage of the complex molecule lifecycle.

Molecule lifecycle services at Sterling

With the rising complexity of APIs in the pipeline today, complete project continuity has become increasingly critical to proactively address challenges, enhance efficiency, minimise costs, streamline development and manufacturing, and accelerate time to market. As a result, pharmaceutical and biotechnology organisations require an outsourced partner with the capabilities to support their product throughout its entire lifecycle, from grams to tonnes. ... Read more

As a full service PDMO®, or partnership development and manufacturing organisation, we have extensive expertise supporting our customers’ molecules from the earliest phases of discovery through to full commercial manufacture. In our global delivery network, our customers will find the world-class facilities, specialised equipment, and highly skilled team members they need to address a wide range of project requirements at every stage—all while benefiting from our simple way of working, our commitment to integrity, and our true scientific collaboration. Read less

Here’s how we accelerate your product’s path to market by delivering unrivalled support at every stage of the pharmaceutical lifecycle.

As our customers prepare for phase I clinical trials, we help them select an appropriate regulatory starting material (RSM) and discern when it makes sense to utilise GMP and non-GMP processes throughout the project. We support them to quickly develop an appropriate amount of product for trials and generate the necessary regulatory data to enhance their chance of success. Through thorough impurity assessments and other quality-centred approaches, we work to ensure the delivery of pure, high-quality products.

Technologies & Services

Knowledge Hub Articles

Brief

Phase One: Molecule Lifecycle Brief

Webinar

BiocatalysisAPI Development

An up-close look at biocatalysis: Accelerating synthesis using nature’s catalysts

Webinar

Solid State Chemistry

Solid form: Why is it important to consider in API development?

Whitepaper

BiocatalysisAPI Development

Biocatalysis whitepaper

Brief

API DevelopmentAPI Manufacturing

Full-lifecycle sustainability

News

API DevelopmentAPI Manufacturing

OncoTEX and Sterling sign clinical manufacturing agreement for development of novel treatment against ovarian cancer

Animation

Solid State ChemistryAPI Development

Material Science at Sterling

Animation

API DevelopmentAPI Manufacturing

Environmental sustainability in the pharmaceutical industry

Animation

Biocatalysis

Biocatalysis: Using enzymes as catalysts

Animation

API DevelopmentAPI Manufacturing

An overview of Sterling Pharma Solutions

Animation

High Potency APIAPI Manufacturing

High Potency APIs are on the rise

Webinar

High Potency APIAPI Manufacturing

Positioning your HPAPI programme for success webinar

News

High Potency APIAPI Manufacturing

Sterling Pharma Solutions acquires Alcami Germantown facility in US

Blog

Solid State Chemistry

Meet our solid state experts

Article

Flow ChemistryAPI Manufacturing

API manufacturing – exploring continuous processing

Article

API DevelopmentAPI Manufacturing

Sterling: A journey with Chromeleon CDS

Article

API DevelopmentAPI Manufacturing

Your Chromatography Data System – are you in control?

Article

Controlled SubstanceAPI Development

Outsourcing the development of controlled substance APIs

News

Sterling partners with Newcastle University to offer PhD project

News

API DevelopmentAPI Manufacturing

Sterling Pharma Solutions announces acquisition of CiVentiChem in the US